Literature DB >> 27040050

Changes in foot function, disease activity, and disability after forefoot resection arthroplasty in patients with rheumatoid arthritis.

Fusakazu Sawachika1, Hirokazu Uemura, Sakurako Katsuura-Kamano, Miwa Yamaguchi, Tirani Bahari, Keisuke Miki, Satoshi Todo, Masayuki Inoo, Ikuko Onishi, Noriyuki Kurata, Kokichi Arisawa.   

Abstract

The purpose of this study was to investigate the changes in foot function, disease activity, and disability in patients with RA after resection arthroplasty of the forefoot (arthroplasty). Arthroplasty was performed on 11 patients with RA. All study patients underwent clinical assessment to measure disease activity (Disease Activity Score in 28 Joints-C-reactive protein, DAS28-CRP), disability (Health Assessment Questionnaire-Disability Index, HAQ-DI) and foot function (Foot Function Index, FFI) at the following stages: preoperatively and 1, 3, and 12 months after surgery. Following arthroplasty, foot function improved significantly, as assessed by FFI total and subscales (pain, disability, and limitation of activity) (P<0.001, P<0.001, P<0.001, and P=0.002, respectively). Disease activity was significantly improved in relation to DAS28-CRP and its subscales of number of swollen joints and patient global assessment (PtGA) (P=0.033, P=0.008, and P=0.038, respectively). There was no significant difference in disability, as assessed by the HAQ-DI and its subscale, HAQ-walking (P=0.150 and P=0.597, respectively). Foot function improved significantly after arthroplasty, and was maintained at 12 months postoperatively. Additionally, our study showed that disease activity and its subscale PtGA improved after arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27040050     DOI: 10.2152/jmi.63.38

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  1 in total

1.  Adaptation and Validation of the Foot Function Index-Revised Short Form into Polish.

Authors:  Radosław Rutkowski; Małgorzata Gałczyńska-Rusin; Małgorzata Gizińska; Marcin Straburzyński-Lupa; Agata Zdanowska; Mateusz Wojciech Romanowski; Wojciech Romanowski; Elly Budiman-Mak; Anna Straburzyńska-Lupa
Journal:  Biomed Res Int       Date:  2017-11-27       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.